Corticotroph Pituitary Carcinoma in a Patient With Lynch Syndrome (LS) and Pituitary Tumors in a Nationwide LS Cohort

Novel Genetic Causes of Pituitary Adenomas

(2016) F. Caimari et al.   CLINICAL CANCER RESEARCH

Leveraging premalignant biology for immune-based cancer prevention

(2016) Avrum Spira et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The epidemiology of pituitary adenomas in Iceland, 1955–2012: a nationwide population-based study

(2015) Tomas Thor Agustsson et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide

(2015) Daniel Bengtsson et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

(2015) Dung T. Le et al.   NEW ENGLAND JOURNAL OF MEDICINE

Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 Mutations

(2015) Patrick Joost et al.   UROLOGY

DNA Mismatch Repair Protein (MSH6) Correlated With the Responses of Atypical Pituitary Adenomas and Pituitary Carcinomas to Temozolomide: The National Cooperative Study by the Japan Society for Hypothalamic and Pituitary Tumors

(2013) Toshio Hirohata et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Adrenocortical Carcinoma Is a Lynch Syndrome–Associated Cancer

(2013) Victoria M. Raymond et al.   JOURNAL OF CLINICAL ONCOLOGY

High Response Rates and Prolonged Survival in Patients With Corticotroph Pituitary Tumors and Refractory Cushing Disease From Capecitabine and Temozolomide (CAPTEM)

(2013) Brad E. Zacharia et al.   NEUROSURGERY

Pituitary Carcinoma: Difficult Diagnosis and Treatment

(2011) Anthony P. Heaney   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

A Mechanism of Acquiring Temozolomide Resistance During Transformation of Atypical Prolactinoma Into Prolactin-Producing Pituitary Carcinoma: Case Report

(2011) Mineko Murakami et al.   NEUROSURGERY